Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in New Orleans. This program offered ...

Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, successfully sponsored and participated in the 4th Sichuan Medical Association Thyroid Disease ...

There’s a stigma surrounding liver cancer. Once you tell people you’ve got it, often you sense a slight judgment. “Oh”, you ...

Liver cancer, or hepatic cancer, is a malignant tumour that grows on the surface or inside the liver. The leading cause is a viral infection with hepatitis B or C virus. The most frequent liver ...

Introduction Pulsed-field ablation (PFA) is a novel modality for pulmonary vein isolation in patients with atrial fibrillation (AF). We describe the initial uptake and experience of PFA using a ...

However, untreated cirrhosis can eventually lead to liver failure or liver cancer, both of which are life-threatening. “Most of the time [steatosis of the liver] is seen on imaging of the liver such ...

Patients with late-stage cancer often have to endure multiple rounds of different types of treatment ... and at the same time achieve thermal ablation of the tumor cells.” To optimize the treatment ...

Liver cancer, one of the leading causes of cancer-related deaths worldwide, has seen a steady rise in both diagnosis and treatment demand over the past few decades. With the rapid advancements in ...

Liver cancer remains one of the most formidable challenges in modern medicine, characterized by its high incidence and mortality rate. Emerging evidence underscores the critical roles of the immune ...

Pulsed field ablation (PFA) is a promising treatment for atrial fibrillation. We report 1-year freedom from atrial arrhythmia outcomes using monopolar PFA delivered through 3 commercial, contact force ...

Detroit — The Barbara Ann Karmanos Cancer Institute on Wednesday announced that it is the first institute in the world to prescribe a new special kind of treatment for advanced liver cancer at ...

Survival for pancreatic and liver cancers in the EU remains very low compared to many other cancers. For pancreatic cancer, survival ranged from 5.5 per cent in Malta to 13.7 per cent in Latvia ...